tiprankstipranks
Adverum Biotechnologies Advances in Gene Therapy Development
PremiumCompany AnnouncementsAdverum Biotechnologies Advances in Gene Therapy Development
18d ago
Adverum Biotechnologies reports Q3 EPS ($1.30), consensus ($1.31)
Premium
The Fly
Adverum Biotechnologies reports Q3 EPS ($1.30), consensus ($1.31)
19d ago
Adverum Biotechnologies appoints Jason Mitchell as CCO
Premium
The Fly
Adverum Biotechnologies appoints Jason Mitchell as CCO
1M ago
Adverum Biotechnologies price target lowered to $40 from $60 at Truist
PremiumThe FlyAdverum Biotechnologies price target lowered to $40 from $60 at Truist
3M ago
Adverum Biotechnologies price target lowered to $12 from $15 at RBC Capital
Premium
The Fly
Adverum Biotechnologies price target lowered to $12 from $15 at RBC Capital
3M ago
Adverum Biotechnologies reports Q2 EPS (89c), consensus ($1.47)
Premium
The Fly
Adverum Biotechnologies reports Q2 EPS (89c), consensus ($1.47)
3M ago
4D Molecular price target lowered to $40 from $63 at BMO Capital
PremiumThe Fly4D Molecular price target lowered to $40 from $63 at BMO Capital
4M ago
Adverum Biotechnologies to host conference call
Premium
The Fly
Adverum Biotechnologies to host conference call
4M ago
Adverum Biotechnologies presents 26-week interim analysis of Ixo-vec trial
Premium
The Fly
Adverum Biotechnologies presents 26-week interim analysis of Ixo-vec trial
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100